iBio, Inc.
(NYSE Amex Equities : IBIO)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. 5.60%219.900.0%$1926.34m
BIIBBiogen, Inc. -1.61%374.791.7%$1313.54m
SNSSSunesis Pharmaceuticals, Inc. -7.33%11.880.7%$830.46m
NVAXNovavax, Inc. 7.25%194.1179.8%$805.05m
AMGNAmgen, Inc. -0.10%239.991.3%$662.77m
BNTXBioNTech SE 3.76%234.600.0%$573.76m
VRTXVertex Pharmaceuticals, Inc. 0.52%188.671.9%$536.86m
GILDGilead Sciences, Inc. -0.39%67.091.0%$496.08m
REGNRegeneron Pharmaceuticals, Inc. 0.05%534.532.7%$388.60m
ILMNIllumina, Inc. 0.67%464.123.5%$351.70m
ALXNAlexion Pharmaceuticals, Inc. -0.56%179.652.0%$338.01m
OCGNOcugen, Inc. -5.88%6.970.0%$322.76m
TXG10X Genomics, Inc. 0.01%197.900.0%$177.36m
EXASEXACT Sciences Corp. 0.47%128.2618.1%$177.23m
TECHBio-Techne Corp. 0.03%440.364.5%$163.90m

Company Profile

iBio, Inc. is a biotechnology company, which engages in the development and manufacture of biotherapeutics. Its pipeline include idiopathic pulmonary fibrosis, systemic sclerosis, and scleroderma. The firm operates through the iBio, Inc. and iBio CDMO business segments. The company was founded by Robert B. Kay on April 15, 1993 and is headquartered in Bryan, TX.